190 related articles for article (PubMed ID: 9365188)
1. Aberrant expression of aromatase in breast cancer tissues.
Harada N
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):175-84. PubMed ID: 9365188
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of aberrant expression of aromatase in breast cancer tissues.
Harada N; Honda S
Breast Cancer Res Treat; 1998; 49 Suppl 1():S15-21; discussion S33-7. PubMed ID: 9797013
[TBL] [Abstract][Full Text] [Related]
3. Gene regulation studies of aromatase expression in breast cancer and adipose stromal cells.
Zhou D; Zhou C; Chen S
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):273-80. PubMed ID: 9365201
[TBL] [Abstract][Full Text] [Related]
4. Malignant breast epithelial cells stimulate aromatase expression via promoter II in human adipose fibroblasts: an epithelial-stromal interaction in breast tumors mediated by CCAAT/enhancer binding protein beta.
Zhou J; Gurates B; Yang S; Sebastian S; Bulun SE
Cancer Res; 2001 Mar; 61(5):2328-34. PubMed ID: 11280806
[TBL] [Abstract][Full Text] [Related]
5. Positive and negative transcriptional regulation of aromatase expression in human breast cancer tissue.
Chen S; Ye J; Kijima I; Kinoshita Y; Zhou D
J Steroid Biochem Mol Biol; 2005 May; 95(1-5):17-23. PubMed ID: 15955695
[TBL] [Abstract][Full Text] [Related]
6. Keratinocyte growth factor (KGF) induces aromatase activity in cultured MCF-7 human breast cancer cells.
Zhang Y; Kulp SK; Sugimoto Y; Farrar WB; Brueggemeier RW; Lin YC
Anticancer Res; 1998; 18(4A):2541-6. PubMed ID: 9703907
[TBL] [Abstract][Full Text] [Related]
7. Presence of alternatively spliced transcripts of aromatase gene in human breast cancer.
Utsumi T; Harada N; Maruta M; Takagi Y
J Clin Endocrinol Metab; 1996 Jun; 81(6):2344-9. PubMed ID: 8964875
[TBL] [Abstract][Full Text] [Related]
8. Molecular and epidemiological analyses of abnormal expression of aromatase in breast cancer.
Harada N; Utsumi T; Takagi Y
Pharmacogenetics; 1995; 5 Spec No():S59-64. PubMed ID: 7581491
[TBL] [Abstract][Full Text] [Related]
9. Organization of the human aromatase p450 (CYP19) gene.
Bulun SE; Takayama K; Suzuki T; Sasano H; Yilmaz B; Sebastian S
Semin Reprod Med; 2004 Feb; 22(1):5-9. PubMed ID: 15083376
[TBL] [Abstract][Full Text] [Related]
10. Unique regulation of expression of human aromatase in the placenta.
Harada N; Yoshimura N; Honda S
J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):327-34. PubMed ID: 14623529
[TBL] [Abstract][Full Text] [Related]
11. Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor alpha.
Kinoshita Y; Chen S
Cancer Res; 2003 Jul; 63(13):3546-55. PubMed ID: 12839940
[TBL] [Abstract][Full Text] [Related]
12. Use of alternative promoters to express the aromatase cytochrome P450 (CYP19) gene in breast adipose tissues of cancer-free and breast cancer patients.
Agarwal VR; Bulun SE; Leitch M; Rohrich R; Simpson ER
J Clin Endocrinol Metab; 1996 Nov; 81(11):3843-9. PubMed ID: 8923826
[TBL] [Abstract][Full Text] [Related]
13. Regulation of aromatase expression in breast cancer tissue.
Bulun SE; Lin Z; Zhao H; Lu M; Amin S; Reierstad S; Chen D
Ann N Y Acad Sci; 2009 Feb; 1155():121-31. PubMed ID: 19250199
[TBL] [Abstract][Full Text] [Related]
14. Aromatase localization in human breast cancer tissues: possible interactions between intratumoral stromal and parenchymal cells.
Miki Y; Suzuki T; Tazawa C; Yamaguchi Y; Kitada K; Honma S; Moriya T; Hirakawa H; Evans DB; Hayashi S; Ohuchi N; Sasano H
Cancer Res; 2007 Apr; 67(8):3945-54. PubMed ID: 17440110
[TBL] [Abstract][Full Text] [Related]
15. Regulation of breast cancer-associated aromatase promoters.
Chen D; Reierstad S; Lu M; Lin Z; Ishikawa H; Bulun SE
Cancer Lett; 2009 Jan; 273(1):15-27. PubMed ID: 18614276
[TBL] [Abstract][Full Text] [Related]
16. Differential regulation of human fibroblast growth factor 1 transcripts provides a distinct mechanism of cell-specific growth factor expression.
Chotani MA; Chiu IM
Cell Growth Differ; 1997 Sep; 8(9):999-1013. PubMed ID: 9300182
[TBL] [Abstract][Full Text] [Related]
17. The role of aromatase and 17-beta-hydroxysteroid dehydrogenase type 1 mRNA expression in predicting the clinical outcome of human breast cancer.
Salhab M; Reed MJ; Al Sarakbi W; Jiang WG; Mokbel K
Breast Cancer Res Treat; 2006 Sep; 99(2):155-62. PubMed ID: 16541304
[TBL] [Abstract][Full Text] [Related]
18. Grape seed extract is an aromatase inhibitor and a suppressor of aromatase expression.
Kijima I; Phung S; Hur G; Kwok SL; Chen S
Cancer Res; 2006 Jun; 66(11):5960-7. PubMed ID: 16740737
[TBL] [Abstract][Full Text] [Related]
19. Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.
Bulun SE; Lin Z; Imir G; Amin S; Demura M; Yilmaz B; Martin R; Utsunomiya H; Thung S; Gurates B; Tamura M; Langoi D; Deb S
Pharmacol Rev; 2005 Sep; 57(3):359-83. PubMed ID: 16109840
[TBL] [Abstract][Full Text] [Related]
20. Endocrine disorders associated with inappropriately high aromatase expression.
Bulun SE; Noble LS; Takayama K; Michael MD; Agarwal V; Fisher C; Zhao Y; Hinshelwood MM; Ito Y; Simpson ER
J Steroid Biochem Mol Biol; 1997 Apr; 61(3-6):133-9. PubMed ID: 9365182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
